Alpha Tau Medical stock hits 52-week high at 15.11 USD

Alpha Tau Medical Ltd's stock has reached a notable 52-week high of $15.11, reflecting a robust 318% increase over the past year. This surge, which has also delivered a 195% return year-to-date and a 108% gain over the past six months, highlights the company's strong performance and investor confidence. Despite the stock being currently overvalued according to InvestingPro data, recent developments such as the completion of patient enrollment for the IMPACT pilot study and positive clinical trial results for Alpha DaRT therapy offer promising outlooks for the company's future.

Brief written by urgent.news from Investing.com's own syndicated text. Machine-written — may contain errors; check the original before relying on it.